Last edition
News about "Concord Biotech"
Concord Biotech Successfully Completes ANVISA Inspection at Limbasi API Manufacturing Facility
Concord Biotech has successfully completed an ANVISA inspection at its Limbasi Active Pharmaceutical Ingredient (API) manufacturing facility, strengthening its regulatory standing and expansion into Brazil's pharmaceutical market.
Concord Biotech | 12/06/2026 | By News Bureau
Concord Biotech | 23/08/2023 | By Sudeep Soparkar | 1427
Concord Biotech files DRHP for IPO
Concord Biotech is the leading global developer and manufacturer of select fermentation-based APIs across immunosuppressants and oncology
Concord Biotech | 16/08/2022 | By Sudeep Soparkar | 1059
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy